HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The perioperative management of patients undergoing combined heart-liver transplantation.

AbstractBACKGROUND:
Combined heart-liver transplantation (CHLT) is an uncommonly performed procedure for patients with coexisting cardiac and liver disease.
METHODS:
A retrospective review was performed of patients undergoing CHLT at our institution from 1999 to 2013. Information related to preoperative organ function, intraoperative management, surgical approach, transfusions, postoperative findings, and 30-day mortality was reviewed.
RESULTS:
Twenty-seven CHLT were performed, with 4 of the 27 including simultaneous kidney transplantation. Familial amyloidosis was the indication for 21 CHLTs (78%), and 12 of these explanted livers were used for domino transplantations. Nineteen patients (70%) were receiving inotropic infusions at the time of organ availability. Median preoperative model for end-stage liver disease score was 12. Liver transplantation immediately preceded cardiac transplantation in 2 of the 27 cases because of the presence of high titer donor-specific antibodies and the potential of the liver to lead to a reduction in the antibody titer. Venovenous bypass was used in 14 operations (52%) which were performed with the caval interposition approach to liver transplantation, cardiopulmonary bypass during liver transplantation in two cases (7%), and no bypass in 11 operations (41%) performed with caval sparing (piggyback) surgical technique. Postoperatively, median duration of mechanical ventilation, intensive care unit stay, and hospital stay until discharge were 1 day, 5.5 days, and 15 days, respectively. Transfusions in the first 48 hr after CHLT were not substantial in most patients. One patient died within 30 days of CHLT.
CONCLUSION:
Combined heart-liver transplantation is a life-saving operation that is performed with relatively low mortality and can be successfully performed in select patients with congenital or acquired cardiac disease.
AuthorsDavid W Barbara, Kent H Rehfeldt, Julie K Heimbach, Charles B Rosen, Richard C Daly, James Y Findlay
JournalTransplantation (Transplantation) Vol. 99 Issue 1 Pg. 139-44 (Jan 2015) ISSN: 1534-6080 [Electronic] United States
PMID25140806 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Blood Transfusion
  • Female
  • Heart Diseases (complications, diagnosis, mortality, surgery)
  • Heart Transplantation (adverse effects, mortality)
  • Humans
  • Intensive Care Units
  • Kidney Transplantation
  • Length of Stay
  • Liver Diseases (complications, diagnosis, mortality, surgery)
  • Liver Transplantation (adverse effects, mortality)
  • Male
  • Middle Aged
  • Minnesota
  • Perioperative Care
  • Postoperative Complications (mortality, therapy)
  • Respiration, Artificial
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: